Cytosorbents (CTSO) Current Assets (2010 - 2026)
Cytosorbents posted quarterly Current Assets of $17.8 million for Q1 2026, down 30.13% year-on-year from $25.4 million in Q1 2025, and down 13.94% on a QoQ basis from $20.6 million in Q4 2025.
Cytosorbents (CTSO) has 17 years of Current Assets data on file, last reported at $17.8 million in Q1 2026.
- For the quarter ending Q1 2026, Current Assets fell 30.13% year-over-year to $17.8 million; the trailing twelve-month figure through Mar 2026 stood at $17.8 million (down 30.13% YoY), and the FY2025 full-year result was $20.6 million, down 4.49% from the prior year.
- Current Assets for Q1 2026 stood at $17.8 million, down from $20.6 million in the prior quarter.
- Across five years, Current Assets topped out at $55.9 million in Q1 2022 and bottomed at $16.6 million in Q3 2024.
- The 5-year median for Current Assets is $23.0 million (2025), against an average of $26.4 million.
- The widest annual swing landed in 2022, when Current Assets slumped 55.49%; it then grew 28.41% in 2025.
- A 5-year view of Current Assets shows it stood at $33.8 million in 2022, then decreased by 24.77% to $25.4 million in 2023, then decreased by 14.94% to $21.6 million in 2024, then slipped by 4.49% to $20.6 million in 2025, then decreased by 13.94% to $17.8 million in 2026.
- The last three Current Assets figures came in at $17.8 million (Q1 2026), $20.6 million (Q4 2025), and $21.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 25.51 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.34 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 24.07 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 8.68 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 6.23 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 11.45 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 4.33 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.43 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.39 Bn |
| 10 | Cytosorbents | 28.81 Mn | 24.01 Mn | 6.13 Mn | 17.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.76 Mn |
| Dec 31, 2025 | 20.63 Mn |
| Sep 30, 2025 | 21.31 Mn |
| Jun 30, 2025 | 22.99 Mn |
| Mar 31, 2025 | 25.41 Mn |
| Dec 31, 2024 | 21.60 Mn |
| Sep 30, 2024 | 16.60 Mn |
| Jun 30, 2024 | 21.96 Mn |
| Mar 31, 2024 | 19.99 Mn |
| Dec 31, 2023 | 25.40 Mn |
| Sep 30, 2023 | 19.26 Mn |
| Jun 30, 2023 | 23.64 Mn |
| Mar 31, 2023 | 28.16 Mn |
| Dec 31, 2022 | 33.76 Mn |
| Sep 30, 2022 | 32.38 Mn |
| Jun 30, 2022 | 41.65 Mn |
| Mar 31, 2022 | 55.85 Mn |
| Dec 31, 2021 | 64.30 Mn |
| Sep 30, 2021 | 72.75 Mn |
| Jun 30, 2021 | 77.08 Mn |
| Mar 31, 2021 | 79.63 Mn |
| Dec 31, 2020 | 82.45 Mn |
| Sep 30, 2020 | 96.80 Mn |
| Jun 30, 2020 | 41.95 Mn |
| Mar 31, 2020 | 37.53 Mn |
| Dec 31, 2019 | 20.90 Mn |
| Sep 30, 2019 | 22.35 Mn |
| Jun 30, 2019 | 22.21 Mn |
| Mar 31, 2019 | 24.83 Mn |
| Dec 31, 2018 | 28.26 Mn |
| Sep 30, 2018 | 29.95 Mn |
| Jun 30, 2018 | 30.78 Mn |
| Mar 31, 2018 | 24.52 Mn |
| Dec 31, 2017 | 20.74 Mn |
| Sep 30, 2017 | 19.39 Mn |
| Jun 30, 2017 | 19.74 Mn |
| Mar 31, 2017 | 6.28 Mn |
| Dec 31, 2016 | 7.83 Mn |
| Sep 30, 2016 | 9.05 Mn |
| Jun 30, 2016 | 11.07 Mn |
| Mar 31, 2016 | 8.04 Mn |
| Dec 31, 2015 | 9.86 Mn |
| Dec 31, 2014 | 7.61 Mn |
| Sep 30, 2014 | 8.95 Mn |
| Jun 30, 2014 | 10.62 Mn |
| Mar 31, 2014 | 11.83 Mn |
| Dec 31, 2013 | 3.49 Mn |
| Sep 30, 2013 | 3.64 Mn |
| Jun 30, 2013 | 2.59 Mn |
| Mar 31, 2013 | 2.13 Mn |
| Dec 31, 2012 | 2.94 Mn |
| Sep 30, 2012 | 2.86 Mn |
| Jun 30, 2012 | 2.47 Mn |
| Mar 31, 2012 | 2.36 Mn |
| Dec 31, 2011 | 1.70 Mn |
| Sep 30, 2011 | 2.52 Mn |
| Jun 30, 2011 | 3.45 Mn |
| Dec 31, 2010 | 1.40 Mn |